Evidence map›Paper›PMID 39764057›Full record

ArticlebioRxiv : the preprint server for biology2024

Same-Slide Spatial Multi-Omics Integration Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Yao Yu Yeo, Yuzhou Chang, Huaying Qiu, Stephanie Pei Tung Yiu, Hendrik A Michel, Wenrui Wu, Xiaojie Jin, Shoko Kure, Lindsay Parmelee, Shuli Luo and 43 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

53 authors.

Yao Yu YeoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Yuzhou ChangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Huaying QiuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Stephanie Pei Tung YiuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Hendrik A MichelCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Wenrui WuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Xiaojie JinPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.
Shoko KureDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Lindsay ParmeleeCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Shuli LuoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Precious CramerCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Jia Le LeeCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Yang WangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Jason YeungCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Nourhan El AhmarDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Berkay SimsekDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Razan MohannaDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
McKayla Van OrdenTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Wesley LuTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Kenneth J LivakTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Shuqiang LiTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Jahanbanoo ShahryariDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Leandra KingsleyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Reem N Al-HumadiDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sahar NasrDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Dingani NkosiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Sam SadighDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Philip RockDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States.
Leonie FrauenfeldDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
Louisa KaufmannDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
Bokai ZhuBroad Institute of Harvard and MIT, Cambridge, MA, United States.
Ankit BasakBroad Institute of Harvard and MIT, Cambridge, MA, United States.
Nagendra DhanikondaCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Chi Ngai ChanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Jordan KrullPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.
Ye Won ChoDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.
Chia-Yu ChenDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.
Jia Ying Joey LeeBioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Hongbo WangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Bo ZhaoDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Lit-Hsin LooBioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
David M KimDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.
Vassiliki BoussiotisDepartment of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Baochun ZhangDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Alex K ShalekBroad Institute of Harvard and MIT, Cambridge, MA, United States.
Brooke HowittDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sabina SignorettiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Christian M SchürchDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
F Stephan HodiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
W Richard BurackDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States.
Scott J RodigDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Qin MaPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.
Sizun JiangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Funding

Cancer Immune Monitoring and Analysis CenterU24CA224331 · NCI · DANA-FARBER CANCER INST · PI FRANK S HODI, Catherine Ju-Ying Wu · 2017 to 2026
$18.4M
TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
The Role of the Y Chromosome in Bladder Tumor Development, Growth And ProgressionP01CA278732 · NCI · CEDARS-SINAI MEDICAL CENTER · PI Hany Abdel-Malek Abdel-Hafiz · 2023 to 2026
$10.7M
NHP CoreP01AI177687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Boris Dominik Juelg · 2023 to 2026
$7.4M
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell LevelR01AI149672 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2020 to 2024
$4.0M
Spatial-Temporal Dissection of Stratified Host Tissue Responses to Severe acute respiratory syndrome-related coronaviruses in situ to Understand Intra-host PathogenesisDP2AI171139 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Sizun Jiang · 2022 to 2026
$2.3M
Statistical Power Analysis Framework for Multi-Sample and Cross-Platform Spatial Omics ExperimentsR01GM152585 · NIGMS · OHIO STATE UNIVERSITY · PI Dongjun Chung, Qin Ma · 2024 to 2026
$1.2M
SCH: Graph-based Spatial Transcriptomics Computational Methods in Kidney DiseasesR01DK138504 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Michael Thomas Eadon, Qin Ma · 2023 to 2026
$1.1M
NCI NIH HHS P01 CA278732NCI NIH HHS U24 CA224331NIAID NIH HHS DP2 AI171139NIAID NIH HHS P01 AI177687NIAID NIH HHS R01 AI149672NIA NIH HHS U54 AG075931NIDDK NIH HHS R01 DK138504NIGMS NIH HHS R01 GM152585
6 · The paper itself

Abstract

The advent of spatial transcriptomics and spatial proteomics have enabled profound insights into tissue organization to provide systems-level understanding of diseases. Both technologies currently remain largely independent, and emerging same slide spatial multi-omics approaches are generally limited in plex, spatial resolution, and analytical approaches. We introduce IN-situ DEtailed Phenotyping To High-resolution transcriptomics (IN-DEPTH), a streamlined and resource-effective approach compatible with various spatial platforms. This iterative approach first entails single-cell spatial proteomics and rapid analysis to guide subsequent spatial transcriptomics capture on the same slide without loss in RNA signal. To enable multi-modal insights not possible with current approaches, we introduce k-bandlimited Spectral Graph Cross-Correlation (SGCC) for integrative spatial multi-omics analysis. Application of IN-DEPTH and SGCC on lymphoid tissues demonstrated precise single-cell phenotyping and cell-type specific transcriptome capture, and accurately resolved the local and global transcriptome changes associated with the cellular organization of germinal centers. We then implemented IN-DEPTH and SGCC to dissect the tumor microenvironment (TME) of Epstein-Barr Virus (EBV)-positive and EBV-negative diffuse large B-cell lymphoma (DLBCL). Our results identified a key tumor-macrophage-CD4 T-cell immunomodulatory axis differently regulated between EBV-positive and EBV-negative DLBCL, and its central role in coordinating immune dysfunction and suppression. IN-DEPTH enables scalable, resource-efficient, and comprehensive spatial multi-omics dissection of tissues to advance clinically relevant discoveries.

Indexed as

BioinformaticsComputational BiologyDLBCLEBVGraph Signal ProcessingSpatial Multi-OmicsSpatial ProteomicsSpatial TranscriptomicsSystems ImmunologyTumor MicroenvironmentTumor Virus

Identifiers

PMID39764057
PMCPMC11702642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.